<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03876704</url>
  </required_header>
  <id_info>
    <org_study_id>2018MSZC-04</org_study_id>
    <nct_id>NCT03876704</nct_id>
  </id_info>
  <brief_title>Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants</brief_title>
  <official_title>Effects of Fat-soluble Vitamins Supplementation in Early Life on Common Complications and Neural Development in Very Low Birth Weight Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xi’an Gaoxin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>First Affiliated Hospital Xi'an Jiaotong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamins A, D, and E play important roles in humans, such as vision function, immune
      function, bone metabolism, cell growth and differentiation and oxidation resistance.
      Deficiencies in these vitamins will result in a high prevalence of cardiovascular disease,
      infection, bone diseases, etc. Preterm infants, especially very low birth weight infants, are
      at risk of vitamin deficiency. Intravenous perfusion is the most common and widely used
      method to supply vitamins for the specific population in early life. However, the current
      dose of vitamin supplied by intravenous perfusion whether can meet the need of growth and
      development is not sure and the appropriate dose for preterm infants is still uncertain. The
      purpose of this study is to investigate whether current dose of fat-soluble vitamin
      supplementation is enough for very low birth weight infants, the safety of high dose of
      fat-soluble vitamin supplementation, and compare the differences of prevalence of common
      complications, such as bronchopulmonary dysplasia, patent ductus arteriosus, sepsis, anemia,
      and neural development between these two groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 29, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin levels</measure>
    <time_frame>within 72 hours after birth, 4~6 weeks old</time_frame>
    <description>Change from baseline level of vitamin A, vitamin D, and vitamin E at 4~6 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>corrected age of 36 weeks</time_frame>
    <description>The prevalence of bronchopulmonary dysplasia, patent ductus arteriosus, sepsis, anemia, intracranial hemorrhage, extrauterine growth retardation, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neural development</measure>
    <time_frame>corrected age of 40 weeks</time_frame>
    <description>White matter disease of the preterm infant, was semiquantitatively assessed from MRI at term-equivalent age based on an established scoring method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gene polymorphism in vitamin deficiency preterm infants</measure>
    <time_frame>within 72 hours after birth, 4~6 weeks old</time_frame>
    <description>Association of rs4588 polymorphism in vitamin D receptor gene and rs10766197 polymorphism in the cytochrome P450 family 2 subfamily R member 1 gene with baseline level of vitamin D and change in vitamin D level after 4~6 weeks' supplementation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Vitamin A Deficiency</condition>
  <condition>Vitamin D Deficiency</condition>
  <condition>Vitamin E Deficiency</condition>
  <condition>Very Low Birth Weight Infants</condition>
  <condition>Bronchopulmonary Dysplasia</condition>
  <condition>Anemia</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>High dose of fat-soluble vitamins</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fat-soluble vitamins is administered 0.5 piece/kg (equals to 1150 U/kg vitamin A，200 U/kg vitamin D, 3.2 U/kg vitamin E) intravenously every day until the baby achieve full enteral feeding (120 ml/kg), starting with the first dose within 24 hours after birth.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional dose of fat-soluble vitamins</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fat-soluble vitamins is administered 0.1 piece/kg (equals to 230 U/kg vitamin A，40 U/kg vitamin D, 0.64 U/kg vitamin E) intravenously every day until the baby achieve full enteral feeding (120 ml/kg), starting with the first dose within 24 hours after birth.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High dose of fat-Soluble Vitamin</intervention_name>
    <description>Supplementation of 5 times current dose of fat-soluble vitamins by intravenous perfusion</description>
    <arm_group_label>High dose of fat-soluble vitamins</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Conventional dose of fat-Soluble Vitamin</intervention_name>
    <description>Supplementation of the current dose of fat-soluble vitamins by intravenous perfusion</description>
    <arm_group_label>Conventional dose of fat-soluble vitamins</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  admitted to the neonatal intensive care unit (NICU) within 24 hours after birth

          -  gestational age younger than 34 weeks

          -  birth weight less than 1500 gram

          -  informed consent was obtained from the infants' parents or guardians

        Exclusion Criteria:

          -  congenital malformation

          -  chromosomal disease, genetic metabolic diseases

          -  the infants or his/mother has abnormal thyroid function or parathyroid gland function

          -  neonatal necrotizing enterocolitis, diarrhea

          -  intracranial hemorrhage of 3 degrees or above

          -  pulmonary hemorrhage

          -  liver enzymes elevated by more than 2 times, cholestasis

          -  death or discharge against medical advice

          -  refuse to take part in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shuang Liu</last_name>
    <role>Study Director</role>
    <affiliation>First Affiliated Hospital of Xian JiaotongUniversity</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shuang Liu</last_name>
    <phone>008615201524806</phone>
    <email>liushuangpku@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>First Affiliated Hospital of Xian JiaotongUniversity</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xihui Zhou</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Kositamongkol S, Suthutvoravut U, Chongviriyaphan N, Feungpean B, Nuntnarumit P. Vitamin A and E status in very low birth weight infants. J Perinatol. 2011 Jul;31(7):471-6. doi: 10.1038/jp.2010.155. Epub 2011 Jan 13.</citation>
    <PMID>21233795</PMID>
  </reference>
  <reference>
    <citation>Mactier H, Mokaya MM, Farrell L, Edwards CA. Vitamin A provision for preterm infants: are we meeting current guidelines? Arch Dis Child Fetal Neonatal Ed. 2011 Jul;96(4):F286-9. doi: 10.1136/adc.2010.190017. Epub 2011 Jan 17.</citation>
    <PMID>21242240</PMID>
  </reference>
  <reference>
    <citation>Jilani T, Iqbal MP. Vitamin E deficiency in South Asian population and the therapeutic use of alpha-tocopherol (Vitamin E) for correction of anemia. Pak J Med Sci. 2018 Nov-Dec;34(6):1571-1575. doi: 10.12669/pjms.346.15880. Review.</citation>
    <PMID>30559825</PMID>
  </reference>
  <reference>
    <citation>Cho SY, Park HK, Lee HJ. Efficacy and safety of early supplementation with 800 IU of vitamin D in very preterm infants followed by underlying levels of vitamin D at birth. Ital J Pediatr. 2017 May 4;43(1):45. doi: 10.1186/s13052-017-0361-0.</citation>
    <PMID>28472980</PMID>
  </reference>
  <results_reference>
    <citation>Fares S, Sethom MM, Khouaja-Mokrani C, Jabnoun S, Feki M, Kaabachi N. VitaminA, E, and D deficiencies in tunisian very low birth weight neonates: prevalence and risk factors. Pediatr Neonatol. 2014 Jun;55(3):196-201. doi: 10.1016/j.pedneo.2013.09.006. Epub 2013 Nov 26.</citation>
    <PMID>24289974</PMID>
  </results_reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>March 3, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
    <mesh_term>Night Blindness</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Vitamin A Deficiency</mesh_term>
    <mesh_term>Vitamin E Deficiency</mesh_term>
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

